Adrenal: Pheochromocytoma: Difference between revisions

 
Line 50: Line 50:
|'''3%'''
|'''3%'''
|-
|-
|'''von Hippel-Lindau syndrome, type 2'''
|'''<span style="color:#ff0000">Von Hippel-Lindau (VHL), type 2</span>'''
|'''HIPPPEEL'''
|'''<span style="color:#0000ff">HIPPPEEL</span>'''
 
#'''<span style="color:#ff0000">CNS and/or retinal </span><span style="color:#0000ff">H</span><span style="color:#ff0000">emangioblastomas</span>'''
# '''CNS and/or retinal Hemangioblastomas'''
# '''<span style="color:#ff0000">ccRCC (</span><span style="color:#0000ff">I</span><span style="color:#ff0000">ncreased risk) and renal cysts</span>'''
# '''ccRCC (Increased risk) and renal cysts'''
#'''<span style="color:#0000ff">P</span><span style="color:#ff0000">heochromocytoma</span>'''
# '''Pheochromocytoma'''
#'''<span style="color:#0000ff">P</span><span style="color:#ff0000">araganglioma</span>'''
# '''Paraganglioma'''
#'''<span style="color:#0000ff">P</span><span style="color:#ff0000">ancreatic neuroendocrine tumours and cysts</span>'''
# '''Pancreatic neuroendocrine tumours and cysts'''
#'''<span style="color:#0000ff">E</span><span style="color:#ff0000">pididymal cystadenoma</span>'''
# '''Epididymal cystadenoma'''
#'''<span style="color:#ff0000">Ear </span><span style="color:#0000ff">E</span><span style="color:#ff0000">ndolymphatic sac tumour</span>'''
# '''Ear Endolymphatic sac tumour'''
#'''<span style="color:#ff0000">Broad </span><span style="color:#0000ff">L</span><span style="color:#ff0000">igament tumours</span>'''
# '''Broad Ligament tumours'''
|10-20%
|10-20%
|5%
|5%